Academic Journal

New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents

التفاصيل البيبلوغرافية
العنوان: New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents
المؤلفون: Ilya A. Shutkov, Yulia N. Okulova, Dmitrii M. Mazur, Nikolai A. Melnichuk, Denis A. Babkov, Elena V. Sokolova, Alexander A. Spasov, Elena R. Milaeva, Alexey A. Nazarov
المصدر: Pharmaceutics, Vol 15, Iss 5, p 1366 (2023)
بيانات النشر: MDPI AG, 2023.
سنة النشر: 2023
المجموعة: LCC:Pharmacy and materia medica
مصطلحات موضوعية: ruthenium compounds, lonidamine, antiproliferative activity, ligand exchange, mode of action, Pharmacy and materia medica, RS1-441
الوصف: The combination of one molecule of organic and metal-based fragments that exhibit antitumor activity is a modern approach in the search for new promising drugs. In this work, biologically active ligands based on lonidamine (a selective inhibitor of aerobic glycolysis used in clinical practice) were introduced into the structure of an antitumor organometallic ruthenium scaffold. Resistant to ligand exchange reactions, compounds were prepared by replacing labile ligands with stable ones. Moreover, cationic complexes containing two lonidamine-based ligands were obtained. Antiproliferative activity was studied in vitro by MTT assays. It was shown that the increase in the stability in ligand exchange reactions does not influence cytotoxicity. At the same time, the introduction of the second lonidamine fragment approximately doubles the cytotoxicity of studied complexes. The ability to induce apoptosis and caspase activation in tumour cell MCF7 was studied by employing flow cytometry.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 15051366
1999-4923
Relation: https://www.mdpi.com/1999-4923/15/5/1366; https://doaj.org/toc/1999-4923
DOI: 10.3390/pharmaceutics15051366
URL الوصول: https://doaj.org/article/0bd7d89685c443d9b8dc0b254006d427
رقم الانضمام: edsdoj.0bd7d89685c443d9b8dc0b254006d427
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:15051366
19994923
DOI:10.3390/pharmaceutics15051366